Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma
Glioma represents a dominant primary intracranial malignancy in the central nervous
system. Artificial intelligence that mainly includes machine learning, and deep learning …
system. Artificial intelligence that mainly includes machine learning, and deep learning …
Treatment response and prognosis evaluation in high‐grade glioma: an imaging review based on MRI
Q Zhou, C Xue, X Ke, J Zhou - Journal of Magnetic Resonance …, 2022 - Wiley Online Library
In recent years, the development of advanced magnetic resonance imaging (MRI)
technology and machine learning (ML) have created new tools for evaluating treatment …
technology and machine learning (ML) have created new tools for evaluating treatment …
Targeted immunoimaging of tumor‐associated macrophages in orthotopic glioblastoma by the NIR‐IIb nanoprobes
Developing dynamic and highly sensitive methods for imaging M2‐type tumor‐associated
macrophages (TAMs) is vital for monitoring the tumor progression and assessing the …
macrophages (TAMs) is vital for monitoring the tumor progression and assessing the …
Immune infiltrating cells-derived risk signature based on large-scale analysis defines immune landscape and predicts immunotherapy responses in glioma tumor …
The glioma tumor microenvironment (TME), composed of several noncancerous cells and
biomolecules is known for its complexity of cancer-immune system interaction. Given that …
biomolecules is known for its complexity of cancer-immune system interaction. Given that …
Characterization of fatty acid metabolism-related genes landscape for predicting prognosis and aiding immunotherapy in glioma patients
Glioma is a highly malignant brain tumor with a poor survival rate. The involvement of fatty
acid metabolism in glioma was examined to find viable treatment options. The information …
acid metabolism in glioma was examined to find viable treatment options. The information …
JMJD8 is an M2 macrophage biomarker, and it associates with DNA damage repair to facilitate stemness maintenance, chemoresistance, and immunosuppression in …
Background JMJD8 has recently been identified as a cancer-related gene, but current
studies provide limited information. We aimed to clarify its roles and the potential …
studies provide limited information. We aimed to clarify its roles and the potential …
Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment
X Deng, X Sun, Z Hu, Y Wu, C Zhou, J Sun… - The FASEB …, 2023 - Wiley Online Library
Although the role of N6‐Methyladenosine (m6A) methylation factors has been established in
multiple cancer types, its involvement in glioblastoma multiforme (GBM) remains limited …
multiple cancer types, its involvement in glioblastoma multiforme (GBM) remains limited …
CD74 correlated with malignancies and immune microenvironment in gliomas
S Xu, X Li, L Tang, Z Liu, K Yang… - Frontiers in molecular …, 2021 - frontiersin.org
Background: Cluster of differentiation 74 (CD74) is found to be highly involved in the
development of various types of cancers and could affect the activities of infiltrated cells in …
development of various types of cancers and could affect the activities of infiltrated cells in …
The CXCL family contributes to immunosuppressive microenvironment in gliomas and assists in gliomas chemotherapy
Gliomas are a type of malignant central nervous system tumor with poor prognosis.
Molecular biomarkers of gliomas can predict glioma patient's clinical outcome, but their …
Molecular biomarkers of gliomas can predict glioma patient's clinical outcome, but their …
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing
Purpose Glioblastoma (GBM) is the most common and deadly brain tumor. We aimed to
reveal potential prognostic GBM marker genes, elaborate their functions, and build an …
reveal potential prognostic GBM marker genes, elaborate their functions, and build an …